Related Experiment Video
Updated: Jul 14, 2026

08:14
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
Published on: October 26, 2017
Abstract:
Investigators offer potential new screening options for the early diagnosis of lung cancer. It is the deadliest cancer by far-largely because it's rarely detected early on. However, new screening approaches may soon give providers and patients powerful new weaponry against this disease.
Insights
New screening methods could improve early lung cancer detection. These advancements offer hope for better patient outcomes against this deadly disease.
Area of Science:
- Oncology
- Medical Diagnostics
- Pulmonology
Background:
- Lung cancer is the leading cause of cancer-related mortality worldwide.
- Late-stage diagnosis significantly contributes to the poor prognosis of lung cancer.
- Effective early detection remains a critical unmet need in lung cancer management.
Purpose of the Study:
- To introduce and evaluate novel screening strategies for early lung cancer diagnosis.
- To enhance the capabilities of current diagnostic tools for lung cancer.
- To provide clinicians and patients with advanced options for lung cancer detection.
Main Methods:
- Exploration of innovative biomarker-based screening approaches.
- Assessment of novel imaging techniques for detecting early-stage lung nodules.
- Development of risk-stratification models for targeted screening.
Main Results:
- Identification of promising new biomarkers indicative of early lung cancer.
- Demonstration of improved sensitivity and specificity in novel screening modalities.
- Validation of risk models for predicting individual lung cancer risk.
Conclusions:
- Emerging screening options show significant potential for improving early lung cancer diagnosis.
- These advancements represent a crucial step forward in combating lung cancer mortality.
- New screening approaches may empower providers and patients with effective tools against lung cancer.